{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:40:34Z","timestamp":1777387234980,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004916","name":"FAPEAM","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.humimm.2014.08.198","type":"journal-article","created":{"date-parts":[[2014,9,5]],"date-time":"2014-09-05T09:20:14Z","timestamp":1409908814000},"page":"1075-1083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-\u03b1 polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients"],"prefix":"10.1016","volume":"75","author":[{"given":"Andr\u00e9a Monteiro","family":"Tarrag\u00f4","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allyson Guimar\u00e3es","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Paulo Diniz","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samara Tatielle Monteiro","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Bonfim","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritesh","family":"Lalwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Ruth S.","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flamir","family":"da Silva Vict\u00f3ria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maril\u00fa Barbieri","family":"Vict\u00f3ria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio Carlos Ros\u00e1rio","family":"Vallinoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Sadahiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Malheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2014.08.198_b0005","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","article-title":"Global epidemiology of hepatitis C virus infection","volume":"5","author":"Shepard","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.humimm.2014.08.198_b0010","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2014.08.198_b0015","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/jhep.2001.27831","article-title":"Estimating progression to cirrhosis in chronic hepatitis C virus infection","volume":"34","author":"Freeman","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2014.08.198_b0020","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.bbrc.2008.12.114","article-title":"Th1 and Th2 cytokines are elevated in HCV-infected SVR(\u2212) patients treated with interferon-\u03b1","volume":"379","author":"Wan","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.humimm.2014.08.198_b0025","first-page":"22","article-title":"Th1 cytokine profiles in hepatitis C virus infected patients and their contributions to inflammatory responses","volume":"8","author":"Najafizadeh","year":"2007","journal-title":"Shiraz E-Med J"},{"key":"10.1016\/j.humimm.2014.08.198_b0030","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CMR.13.2.223-235.2000","article-title":"Clinical significance of hepatitis C virus genotypes","volume":"13","author":"Zein","year":"2000","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.humimm.2014.08.198_b0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2014.08.198_b0040","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1440-1746.2011.06918.x","article-title":"Host genomics and HCV treatment response","volume":"27","author":"Clark","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.humimm.2014.08.198_b0045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/medicina44070066","article-title":"Viral clearance or persistence after acute hepatitis C infection: interim results from a prospective study","volume":"44","author":"Guouzaire","year":"2008","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.humimm.2014.08.198_b0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.imlet.2013.07.010","article-title":"Dual role of IL-12 in the therapeutic efficacy or failure during combined PEG-interferon-\u03b12A and ribavirin therapy in patients with chronic hepatitis C","volume":"154","author":"Ara\u00fajo","year":"2013","journal-title":"Immunol Lett"},{"key":"10.1016\/j.humimm.2014.08.198_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/468107","article-title":"Cytokines and HCV-related disorders","volume":"468107","author":"Fallahi","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.humimm.2014.08.198_b0060","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/sj.gene.6363824","article-title":"Polymorphisms in or near tumour necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF production","volume":"3","author":"Jong","year":"2002","journal-title":"Genes Immun"},{"key":"10.1016\/j.humimm.2014.08.198_b0065","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI2629","article-title":"The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis","volume":"102","author":"Fishman","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humimm.2014.08.198_b0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00251-010-0491-7","article-title":"Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C","volume":"63","author":"Cussigh","year":"2011","journal-title":"Immunogenetics"},{"key":"10.1016\/j.humimm.2014.08.198_b0075","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.510300207","article-title":"Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa","volume":"30","author":"Edwards-Smith","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2014.08.198_b0080","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1053\/jhep.2001.22347","article-title":"Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection","volume":"33","author":"Yee","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2014.08.198_b0085","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00251-003-0594-5","article-title":"Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection","volume":"55","author":"Knapp","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.humimm.2014.08.198_b0090","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1590\/S0037-86822011000500024","article-title":"Caracteriza\u00e7\u00e3o do v\u00edrus da hepatite C em pacientes com hepatite Cr\u00f4nica: gen\u00f3tipos no Estado do Amazonas","volume":"44","author":"Ara\u00fajo","year":"2011","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.humimm.2014.08.198_b0095","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1590\/S0100-879X2012007500003","article-title":"Distribution of human immunodeficiency virus type 1 subtypes in the state of Amazonas, Brazil, and subtype C identification","volume":"45","author":"Cunha","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.humimm.2014.08.198_b0100","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nprot.2006.83","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"1","author":"Chomczynski","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.humimm.2014.08.198_b0105","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1128\/JVI.02276-06","article-title":"Progression of fibrosis during chronic hepatitis C is associated with rapid virus evolution","volume":"81","author":"Wang","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.humimm.2014.08.198_b0110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/MCG.0b013e31818be17c","article-title":"Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients","volume":"43","author":"Hu","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.humimm.2014.08.198_b0115","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/hep.510240402","article-title":"Progressive liver injury in chronic hepatitis C infection correlates with increased intrahepatic expression of Th1-associated cytokines","volume":"24","author":"Napoli","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.humimm.2014.08.198_b0120","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1034\/j.1399-0039.2003.00015.x","article-title":"Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease","volume":"61","author":"Yoshizawa","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2014.08.198_b0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cld.2008.03.002","article-title":"Host genetic factors and antiviral immune responses to hepatitis C virus","volume":"12","author":"Thio","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.humimm.2014.08.198_b0130","first-page":"3670","article-title":"Increased frequency of interferon-gamma-producing peripheral blood CD4? T cells in chronic hepatitis C virus infection","volume":"95","author":"Kawakami","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.humimm.2014.08.198_b0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2893.2007.00908.x","article-title":"Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease","volume":"15","author":"Gigi","year":"2008","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.humimm.2014.08.198_b0140","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.humimm.2009.01.019","article-title":"Combined analysis of interferon-\u03b3 and interleukin-10 gene polymorphisms and chronic hepatitis C severity","volume":"70","author":"Bouzgarrou","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.humimm.2014.08.198_b0145","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/sj.gene.6363696","article-title":"Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection","volume":"1","author":"Yee","year":"2000","journal-title":"Genes Immun"},{"key":"10.1016\/j.humimm.2014.08.198_b0150","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12072-010-9232-0","article-title":"Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients","volume":"5","author":"Bouzgarrou","year":"2011","journal-title":"Hepatol Int"},{"key":"10.1016\/j.humimm.2014.08.198_b0155","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jmv.10472","article-title":"Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon gamma, and outcome of hepatitis C virus infection","volume":"71","author":"Barrett","year":"2003","journal-title":"J Med Virol"},{"key":"10.1016\/j.humimm.2014.08.198_b0160","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.3748\/wjg.v11.i42.6656","article-title":"Effect of cytokine gene polymorphism on histological activity index, viral load and response to treatment in patients with chronic hepatitis C genotype 3","volume":"11","author":"Abbas","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.humimm.2014.08.198_b0165","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1034\/j.1600-0676.2002.01553.x","article-title":"Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy","volume":"22","author":"Constantini","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.humimm.2014.08.198_b0170","first-page":"159","article-title":"Single nucleotide polymorphisms in the interleukin-10 gene promoter and clinical outcome of chronic hepatitis C virus infection","volume":"50","author":"Abe","year":"2003","journal-title":"Jikeikai Med J"},{"key":"10.1016\/j.humimm.2014.08.198_b0175","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jhep.2006.07.026","article-title":"Interleukin-10\u20131082 GG polymorphism influences the occurrence and the clinical characteristics of hepatitis C virus infection","volume":"45","author":"Persico","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.humimm.2014.08.198_b0180","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.3748\/wjg.15.5610","article-title":"Polymorphisms of some cytokines and chronic hepatitis B and C virus infection","volume":"15","author":"Gao","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.humimm.2014.08.198_b0185","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0016-5085(03)00899-0","article-title":"A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma","volume":"125","author":"Machado","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.humimm.2014.08.198_b0190","doi-asserted-by":"crossref","DOI":"10.1136\/jmg.2005.032557","article-title":"A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C","volume":"42","author":"Richardson","year":"2005","journal-title":"J Med Genet"},{"key":"10.1016\/j.humimm.2014.08.198_b0195","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/art.23836","article-title":"Ability of epistatic interactions of cytokine single-nucleotide polymorphisms to predict susceptibility to disease subsets in systemic sclerosis patients","volume":"59","author":"Beretta","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.humimm.2014.08.198_b0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/jmv.21716","article-title":"Association of candidate susceptible loci with chronic infection with hepatitis B virus in a Chinese population","volume":"82","author":"Chen","year":"2010","journal-title":"J Med Virol"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885914003978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885914003978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T07:22:47Z","timestamp":1717312967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885914003978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0198885914003978"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2014.08.198","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined impact of hepatitis C virus genotype 1 and interleukin-6 and tumor necrosis factor-\u03b1 polymorphisms on serum levels of pro-inflammatory cytokines in Brazilian HCV-infected patients","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2014.08.198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}